A clinicopathological scoring system to select breast cancer patients for sentinel node biopsy

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1170-1174

  Carmichael, A R ^a   Aparanji, K ^a   Nightingale, P ^c   Boparai, R ^b   Stonelake, P S ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b PRINCESS ROYAL HOSPITAL   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Breast neoplasms; Lymphatic metastasis; Sentinel lymph node biopsy; Surgery

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CLINICAL DECISION MAKING; CONTROLLED STUDY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PATIENT IDENTIFICATION; PATIENT SELECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SENTINEL LYMPH NODE BIOPSY; VALIDATION STUDY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 33751289460     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.05.022     Document Type: Article

References (29)

1. Beechey-Newman N. 10. Sentinel node biopsy in primary breast cancer. Int J Clin Pract 56 2 (2002) 111-115
2. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 2 (1977) 456-466
3. Clarke D., Newcombe R.G., and Mansel R.E. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 11 Suppl. 3 (2004) 211S-215S
4. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 4 (1992) 392-399
5. Gill P.G. Sentinel lymph node biopsy versus axillary clearance in operable breast cancer: the RACS SNAC trial, a multicenter randomized trial of the Royal Australian College of Surgeons (RACS) section of breast surgery, in collaboration with the National Health and Medical Research Council Clinical Trials Center. Ann Surg Oncol 11 Suppl. 3 (2004) 216S-221S
6. Bochner M.A., Farshid G., Dodd T.J., Kollias J., and Gill P.G. Intraoperative imprint cytologic assessment of the sentinel node for early breast cancer. World J Surg 27 4 (2003) 430-432
7. Veronesi U., Zurrida S., Mazzarol G., and Viale G. Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 25 6 (2001) 806-808
8. Salem A.A., Douglas-Jones A.G., Sweetland H.M., and Mansel R.E. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry: I. Protocol of rapid immunostaining of touch imprints. Eur J Surg Oncol 29 1 (2003) 25-28
9. Tew K., Irwig L., Matthews A., Crowe P., and Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 92 9 (2005) 1068-1080
10. Turner R.R., Hansen N.M., Stern S.L., and Giuliano A.E. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 112 5 (1999) 627-634
11. Zgajnar J., Frkovic-Grazio S., Besic N., et al. Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients - results of a large series. J Surg Oncol 85 2 (2004) 82-86
12. Soni N.K., Carmalt H.L., Gillett D.J., and Spillane A.J. Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol (2005)
13. Silverstein M.J., Skinner K.A., and Lomis T.J. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 25 6 (2001) 767-772
14. Bevilacqua J., Cody III H., MacDonald K.A., Tan L.K., Borgen P.I., and Van Zee K.J. A prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location. [Corrected]. Eur J Surg Oncol 28 5 (2002) 490-500
15. Nos C., Harding-MacKean C., Freneaux P., et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 90 11 (2003) 1354-1360
16. Cserni G., Burzykowski T., Vinh-Hung V., et al. Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 34 9 (2004) 519-524
17. Cox C.E., Haddad F., Bass S., et al. Lymphatic mapping in the treatment of breast cancer. Oncology (Williston Park) 12 9 (1998) 1283-1292
18. Estourgie S.H., Nieweg O.E., Olmos R.A., Rutgers E.J., and Kroon B.B. Lymphatic drainage patterns from the breast. Ann Surg 239 2 (2004) 232-237
19. Orucevic A., Reddy V.B., Bloom K.J., et al. Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age. Breast J 8 6 (2002) 349-355
20. Arisio R., Sapino A., Cassoni P., et al. What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?. J Clin Pathol 53 11 (2000) 846-850
21. Anan K., Mitsuyama S., Tamae K., et al. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?. Eur J Surg 166 8 (2000) 610-615
22. Clarke D., Khonji N.I., and Mansel R.E. Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg 25 6 (2001) 819-822
23. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 2 (2005) 231-237
24. Asaad M., Tamer M., and Mokbel K. British women's choice between sentinel node biopsy and axillary node clearance for breast cancer. Curr Med Res Opin 19 6 (2003) 570-574
25. Singh R.G., and Mokbel K. The evolving role of sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 29 5 (2003) 423-425
26. Mokbel K. Axillary node sampling or sentinel node biopsy. Eur J Surg Oncol 29 3 (2003) 288
27. Nason K.S., Anderson B.O., Byrd D.R., et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89 11 (2000) 2187-2194
28. Hoar F.J., and Stonelake P.S. A prospective study of the value of axillary node sampling in addition to sentinel lymph node biopsy in patients with breast cancer. Eur J Surg Oncol 29 6 (2003) 526-531
29. Fisher B.J., Perera F.E., Cooke A.L., et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?. Int J Radiat Oncol Biol Phys 38 3 (1997) 551-559